Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation

SAN JOSE, CALIFORNIA, 23 August, 2023- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D World Magazine, often referred to as the “Oscars of Innovation”.

argenx wins EMA CHMP nod for subcutaneous Vyvgart in myasthenia gravis – Pharmaceutical Technology

Vyvgart is argenx’s high-grossing drug, having generated $269m in Q2 2023. Image Credit: Kateryna Kon / Shutterstock. The Committee for Medicinal Products for Human Use

September 15, 2023

Long-term benefits of plant-based diet and lifestyle intervention in RA patients

The 16-week Plants for Joints trial investigated the effects of a multidisciplinary lifestyle intervention in people with RA, as compared to usual care.

June 17, 2024

Shire stock buyout news

April 16, 2018

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.